跳至主要内容
临床试验/CTRI/2025/12/098929
CTRI/2025/12/098929尚未招募不适用

Effect of Individualized Homoeopathic Medicine selected using Boerickes Pocket Manual Repertory in cases of Menopausal Syndrome assessed by Menopausal Rating Scale: A Prospective Interventional Study

Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Marked Improvement

研究概览

简要总结

This study addresses menopausal syndrome, a common condition characterized by vasomotor, psychological, somatic, and urogenital symptoms resulting from oestrogen deficiency in middle-aged women, which has a high epidemiological burden due to increasing life expectancy. There is a research gap in systematically generated clinical evidence evaluating the effectiveness of individualized homoeopathic treatment using standardized assessment tools. The study uses the Menopause Rating Scale (MRS) to assess symptom severity and therapeutic response. This prospective interventional single arm clinical study aims to evaluate the effect of individualized homoeopathic medicines selected through Boericke’s Pocket Manual Repertory in cases of Menopausal Syndrome with objectives to assess baseline symptoms, monitor improvement. Forty eligible participants will be recruited from Jawaharlal Nehru Homoeopathic Medical College and Hospital, Vadodara, Gujarat, over a study period of one year. This prospective study expects to demonstrate a significant reduction in MRS scores, supporting the role of individualized homoeopathy as a safe and effective management option for menopausal syndrome.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 60.00 Year(s)(—)
性别
Female

入选标准

  • •Women Aged 40-60 Years with Natural Menopause Stage 1 to Stage 2B According to Menopausal Staging by Dr Behram Anklesaria
  • •Women presenting with Menopausal Symptoms with a Menopausal Rating Scale Score less than or is Equal to
  • •All Socio- Economic Status.
  • •Patients who willing to give Informed Consent and Maintaining Follow Up.

排除标准

  • •Surgical or Chemically induced Menopause.
  • •Women who are currently on or have taken Hormonal Replacement Therapy or other Alternative Therapies.
  • •Known or Suspected Malignancy.
  • •Presence of Major or Sever Systemic Illness.

结局指标

主要结局

Marked Improvement

时间窗: 6 Months

Moderate Improvement

时间窗: 6 Months

Mild Improvement

时间窗: 6 Months

No Significant Improvement

时间窗: 6 Months

Status Quo

时间窗: 6 Months

Any Increase in Menopausal Rating Scale Score will be counted as worse

时间窗: 6 Months

次要结局

未报告次要终点

研究者

发起方
Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Asmabanu Patel

Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University

研究点 (1)

Loading locations...

相似试验